Dr. Stephen Henry, M.D

NPI: 1811925183
Total Payments
$26,736
2024 Payments
$3,494
Companies
88
Transactions
1,244
Medicare Patients
22,987
Medicare Billing
$2.9M

Payment Breakdown by Category

Food & Beverage$24,939 (93.3%)
Consulting$1,625 (6.1%)
Education$172.14 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $24,939 1,231 93.3%
Consulting Fee $1,625 1 6.1%
Education $172.14 12 0.6%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $3,957 86 $0 (2024)
ABBVIE INC. $2,400 118 $0 (2024)
ViiV Healthcare Company $2,130 114 $0 (2024)
Amgen Inc. $1,601 83 $0 (2024)
Gilead Sciences, Inc. $1,551 79 $0 (2024)
Novo Nordisk Inc $1,497 83 $0 (2024)
SANOFI-AVENTIS U.S. LLC $1,052 26 $0 (2022)
PFIZER INC. $1,040 68 $0 (2022)
Bausch Health US, LLC $1,022 67 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $824.93 47 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,494 158 ABBVIE INC. ($507.37)
2023 $3,681 175 ABBVIE INC. ($607.99)
2022 $3,299 161 Janssen Pharmaceuticals, Inc ($481.85)
2021 $4,924 160 Janssen Pharmaceuticals, Inc ($2,181)
2020 $2,950 143 ViiV Healthcare Company ($382.44)
2019 $3,346 161 Novo Nordisk Inc ($429.80)
2018 $2,641 157 SANOFI-AVENTIS U.S. LLC ($287.12)
2017 $2,402 129 SANOFI-AVENTIS U.S. LLC ($450.25)

All Payment Transactions

1,244 individual payment records from CMS Open Payments — Page 1 of 50

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.47 General
Category: Gastroenterology
12/19/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.63 General
Category: PSYCHIATRY
12/16/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $22.00 General
Category: Inflammation
12/10/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.78 General
12/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $31.32 General
Category: RESPIRATORY
12/02/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.33 General
Category: PSYCHIATRY
11/25/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $24.79 General
Category: Neurology
11/18/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $34.77 General
Category: INFLAMMATION AND IMMUNOLOGY
11/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $8.51 General
Category: PSYCHIATRY
11/14/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $23.54 General
Category: Inflammation
11/12/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.51 General
Category: NEUROSCIENCE
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.62 General
Category: NEUROSCIENCE
11/11/2024 Lexicon Pharmaceuticals, Inc. Food and Beverage In-kind items and services $33.19 General
11/05/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $12.30 General
10/31/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.50 General
Category: PSYCHIATRY
10/23/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $9.51 General
Category: Neurology
10/22/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.42 General
10/22/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $17.66 General
Category: PSYCHIATRY
10/21/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $2.81 General
Category: PSYCHIATRY
10/17/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $15.06 General
Category: Insomnia
10/15/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $7.23 General
Category: Inflammation
10/14/2024 Napo Pharmaceuticals Inc Mytesi (Drug) Food and Beverage Cash or cash equivalent $23.09 General
Category: Infectious Disease
10/10/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $36.61 General
Category: Immunology
10/09/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $9.78 General
Category: Neurology
10/08/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $39.69 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 52 6,082 118,248 $2.3M $797,793
2022 57 6,471 102,784 $2.8M $993,512
2021 47 5,419 85,978 $1.9M $687,461
2020 46 5,015 73,414 $9.0M $465,656
Total Patients
22,987
Total Services
380,424
Medicare Billing
$2.9M
Procedure Codes
202

All Medicare Procedures & Services

202 procedure records from CMS Medicare Utilization — Page 1 of 9

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 499 1,874 $431,020 $199,544 46.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 470 746 $205,150 $108,708 53.0%
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc Office 2023 461 2,076 $311,102 $103,839 33.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 431 1,166 $219,208 $85,337 38.9%
J1306 Injection, inclisiran, 1 mg Office 2023 13 6,532 $130,640 $61,441 47.0%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 474 1,499 $89,940 $32,902 36.6%
J0897 Injection, denosumab, 1 mg Office 2023 16 1,740 $45,240 $32,031 70.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 271 2,458 $145,232 $29,178 20.1%
90662 Influenza vaccine split virus, preservative free Office 2023 240 249 $24,901 $17,853 71.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 512 2,038 $109,626 $17,259 15.7%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 235 385 $153,601 $13,214 8.6%
71045 X-ray of chest, 1 view Office 2023 222 478 $76,480 $10,814 14.1%
G0008 Administration of influenza virus vaccine Office 2023 246 255 $10,795 $8,516 78.9%
20610 Aspiration and/or injection of fluid from large joint Office 2023 72 121 $17,063 $7,252 42.5%
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise Office 2023 38 38 $17,100 $6,137 35.9%
J1460 Injection, gamma globulin, intramuscular, 1 cc Office 2023 27 156 $8,092 $5,885 72.7%
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Office 2023 330 330 $8,091 $5,838 72.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 14 52 $13,520 $5,184 38.3%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 119 282 $10,434 $4,623 44.3%
J0561 Injection, penicillin g benzathine, 100,000 units Office 2023 19 276 $7,512 $4,242 56.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 39 82 $5,400 $3,940 73.0%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 22 64 $16,960 $3,767 22.2%
J3121 Injection, testosterone enanthate, 1 mg Office 2023 42 90,240 $54,144 $3,086 5.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 16 18 $6,170 $2,615 42.4%
69210 Removal of impacted ear wax Office 2023 54 64 $4,480 $2,466 55.0%

About Dr. Stephen Henry, M.D

Dr. Stephen Henry, M.D is a Geriatric Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811925183.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Henry, M.D has received a total of $26,736 in payments from pharmaceutical and medical device companies, with $3,494 received in 2024. These payments were reported across 1,244 transactions from 88 companies. The most common payment nature is "Food and Beverage" ($24,939).

As a Medicare-enrolled provider, Henry has provided services to 22,987 Medicare beneficiaries, totaling 380,424 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 202 distinct procedure/service records.

Practice Information

  • Specialty Geriatric Medicine
  • Location Pasadena, CA
  • Active Since 06/28/2006
  • Last Updated 05/18/2011
  • Taxonomy Code 207RG0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1811925183

Products in Payments

  • SPRAVATO (Drug) $3,102
  • DOVATO (Drug) $1,336
  • PRALUENT (Drug) $1,039
  • APLENZIN (Drug) $1,004
  • VRAYLAR (Drug) $985.53
  • ELIQUIS (Drug) $892.44
  • UBRELVY (Drug) $861.22
  • REXULTI (Drug) $788.82
  • Saxenda (Drug) $739.83
  • XARELTO (Drug) $682.34
  • Otezla (Drug) $626.04
  • Repatha (Biological) $522.49
  • Trintellix (Drug) $412.49
  • ENTRESTO (Drug) $388.80
  • TRELEGY ELLIPTA (Drug) $334.88
  • TRIUMEQ (Drug) $308.45
  • NEXLETOL (Drug) $298.63
  • Ozempic (Drug) $294.46
  • XIFAXAN (Drug) $290.70
  • JARDIANCE (Drug) $272.05

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Geriatric Medicine Doctors in Pasadena